Paper7249504
E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.
Mellström B and 4 others. Clin Pharmacol Ther, 1981. Cited by 219 papers, by iCite.
Cite this record
ConductScience Library. E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation. Papers, record 7249504. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7249504
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Debrisoquin | Major topic |
| Isoquinolines | Major topic |
| Nortriptyline | Major topic |
| Female | |
| Humans | |
| Hydroxylation | |
| Kinetics | |
| Male | |
| Phenotype | |
| Stereoisomerism |
Source PubMed
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 219 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39832006 | Validating the accuracy of mathematical model-based pharmacogenomics dose prediction with real-world data. | Eur J Clin Pharmacol | 2025 | https://conductscience.org/library/papers/39832006 | PubMed |
| 35222013 | Pharmacogenetics in Primary Headache Disorders. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/35222013 | PubMed |
| 27942231 | CYP2D6 polymorphisms and their influence on risperidone treatment. | Pharmgenomics Pers Med | 2016 | https://conductscience.org/library/papers/27942231 | PubMed |
| 27520753 | The Role of Metabolites of Antidepressants in the Treatment of Depression. | CNS Drugs | 1997 | https://conductscience.org/library/papers/27520753 | PubMed |
| 25224004 | Pharmacokinetic interaction between nevirapine and nortriptyline in rats: inhibition of nevirapine metabolism by nortriptyline. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/25224004 | PubMed |
| 23226054 | Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family. | Pharmgenomics Pers Med | 2011 | https://conductscience.org/library/papers/23226054 | PubMed |
| 19902987 | Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. | Clin Pharmacokinet | 2009 | https://conductscience.org/library/papers/19902987 | PubMed |
| 17764479 | The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population. | Br J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/17764479 | PubMed |
| 16782768 | 3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio. | Drug Metab Dispos | 2006 | https://conductscience.org/library/papers/16782768 | PubMed |
| 15037866 | Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. | Mol Psychiatry | 2004 | https://conductscience.org/library/papers/15037866 | PubMed |
| 12814461 | Disposition of debrisoquine and nortriptyline in Korean subjects in relation to CYP2D6 genotypes, and comparison with Caucasians. | Br J Clin Pharmacol | 2003 | https://conductscience.org/library/papers/12814461 | PubMed |
| 11851634 | Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. | Br J Clin Pharmacol | 2002 | https://conductscience.org/library/papers/11851634 | PubMed |
| 11735606 | Quantitative pharmacogenetics of nortriptyline: a novel approach. | Clin Pharmacokinet | 2001 | https://conductscience.org/library/papers/11735606 | PubMed |
| 10319193 | Metabolism of tricyclic antidepressants. | Cell Mol Neurobiol | 1999 | https://conductscience.org/library/papers/10319193 | PubMed |
| 9084960 | Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9084960 | PubMed |
| 8867869 | Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype. | Psychopharmacology (Berl) | 1996 | https://conductscience.org/library/papers/8867869 | PubMed |
| 8703653 | The effects of selective serotonin reuptake inhibitors and their metabolites on S-mephenytoin 4'-hydroxylase activity in human liver microsomes. | Br J Clin Pharmacol | 1995 | https://conductscience.org/library/papers/8703653 | PubMed |
| 8491058 | Pharmacokinetic optimisation of tricyclic antidepressant therapy. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8491058 | PubMed |
| 8148364 | Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotyping. | J Psychiatry Neurosci | 1994 | https://conductscience.org/library/papers/8148364 | PubMed |
| 7712660 | Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/7712660 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7249504
GET https://conductscience.org/api/papers/v1/7249504/cited_by?page=2